Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PRospective Multiple Myeloma Impact Study

NCT: NCT02911571 · ACTIVE_NOT_RECRUITING

NCT IDNCT02911571
StatusACTIVE_NOT_RECRUITING
Start Date2018-02-27
Completion2026-10-01

Brief Summary

This will be a prospective, case-only, study to measure the impact of MMprofiler on treatment intention decisions in Multiple Myeloma patients.

Frequently Asked Questions

What is PRospective Multiple Myeloma Impact Study?

PRospective Multiple Myeloma Impact Study is a clinical trial registered under NCT02911571. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT02911571?

The current status of NCT02911571 (PRospective Multiple Myeloma Impact Study) is: ACTIVE_NOT_RECRUITING.

When did PRospective Multiple Myeloma Impact Study start?

PRospective Multiple Myeloma Impact Study started on 2018-02-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑